Navigation Links
Biodel Reports Fourth Quarter and Fiscal Year 2010 Financial Results
Date:12/9/2010

nue during the fiscal years ended September 30, 2010 or 2009.

At September 30, 2010, Biodel had cash, cash equivalents, restricted cash and marketable securities of $29.1 million and 26.4 million shares of common stock outstanding.

Business Review

Since receiving a complete response letter from the U.S. Food and Drug Administration (FDA) in October regarding the NDA for Linjeta™, Biodel has requested a meeting with FDA staff to review the agency's request for new information about the drug.  Biodel plans to meet with the FDA to discuss the agency's comments in the letter and to determine how to satisfy its requests for additional information regarding the efficacy, safety and manufacture of Linjeta™.  

Biodel does not anticipate commencing new pivotal Phase 3 clinical trials with its current formulation of Linjeta™ prior to determining whether one of its other proprietary rapid-acting insulin or insulin analog formulations should be advanced in its place.  These alternate formulations generally use the same or similar excipients as Linjeta™, but may present improvements with regard to injection site discomfort.  In fiscal year 2011, Biodel intends to conduct preclinical studies and Phase 1 clinical trials to determine whether one or more of its newer insulin formulations is likely to offer a combination of pharmacokinetic, stability and tolerability characteristics that is preferable to Linjeta™.  Following its meeting with the FDA regarding Linjeta™ and based on its analysis of the preclinical and Phase 1 clinical data for its alternate formulations, Biodel will determine the number, type and duration of additional trials it will conduct prior to initiating Phase 3 clinical trials with a proprietary rapid-acting insulin.

In November at the Diabetes Technology Meeting in Bethesda, Maryland, the company reported results of a study comparing the pharmacokinetic characteri
'/>"/>

SOURCE Biodel Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Biodel Reports New Findings from Key Programs at Diabetes Technology Meeting
2. Biodel to Present Data from Product Development Programs at 2010 Diabetes Technology Meeting
3. Biodel Awarded $1.2 Million in Therapeutic Discovery Research Grants From IRS
4. FDA Issues Complete Response Letter to Biodel Regarding New Drug Application for Linjeta™
5. Biodel to Present at Upcoming Conferences
6. Biodel Reports Research Progress in Poster Session on Short-Acting Insulins at 46th EASD Annual Meeting
7. Biodel Appoints Arthur Urciuoli to its Board of Directors
8. Biodel to Raise $9.4 Million Through Registered Direct Offering
9. Biodel Announces Schedule for Presentations at the 37th Annual Meeting and Exposition of the Controlled Release Society
10. Biodel Inc. Announces the Completion of Its Two Pivotal Trials and the Release of EASD Abstracts Containing Additional Interim Data From Its VIAject(TM) Program
11. Biodel Inc. Completes Enrollment of Two Pivotal Phase III Clinical Trials of VIAject(TM) and Plans Manufacturing Facility for VIAject(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... , Sept. 19, 2014 Five MinuteClinic walk-in medical clinics ... metropolitan area. Three clinics opened in Memphis ... A fourth clinic will be added in Springfield ... Bartlett is expected to open October 22.  MinuteClinic is ... the United States . The ...
(Date:9/19/2014)...  Lpath, Inc. (NASDAQ: LPTN ), ... today that it has entered into definitive agreements ... and 3,605,042 unregistered warrants in a registered direct ... share of common stock and one unregistered warrant ... will be $3.475.  The warrants have an exercise ...
(Date:9/19/2014)... Intarcia Therapeutics, Inc. today announced the presentation ... ITCA 650 (continuous subcutaneous delivery of exenatide) in type ... the 50 th Annual Meeting of the European ... the open-label, phase 3 FREEDOM-HBL (high baseline) trial showed ... poorly controlled type 2 diabetes. The results were presented ...
Breaking Medicine Technology:MinuteClinic Walk-in Medical Clinics Opening in Memphis 2MinuteClinic Walk-in Medical Clinics Opening in Memphis 3Lpath, Inc. Announces $12.5 Million Registered Direct Offering 2Lpath, Inc. Announces $12.5 Million Registered Direct Offering 3Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 2Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 3Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 4
... 26, 2007 - A new study published ... ("A National Survey of,Physician-Industry Relationships") on the ... the need for,profession-wide and public policy reforms ... that the existing,voluntary PhRMA (Pharmaceutical Research and ...
... 2007 - Aeolus,Pharmaceuticals, Inc. (OTCBB:AOLS) announced today ... of the Journal of Neuroscience a study,by ... National Jewish,Medical and Research Center demonstrating that ... 11207, demonstrated,neuroprotection in an animal model of ...
Cached Medicine Technology:Ties Between Physicians and Drug Companies Still Too Strong: the,Prescription Project Offers Solutions to Prevent Conflicts of,Interest 2Study Demonstrating Aeolus Compound's Neuroprotection in,Parkinson's Disease Published in the Journal of Neuroscience 2Study Demonstrating Aeolus Compound's Neuroprotection in,Parkinson's Disease Published in the Journal of Neuroscience 3
(Date:9/20/2014)... Atlanta, GA (PRWEB) September 20, 2014 ... September 20, 2014. The first poster looked at the ... per cardiac cycle for calculating diastolic function. In conjunction ... with end-stage renal disease and normal LVEF by echo ... high-dose stress protocol, and standard SPECT. Emory Toolbox ...
(Date:9/20/2014)... September 21, 2014 Increases in ... to greater waste treatment volumes. However, government regulations ... waste from landfill. According to IBISWorld industry analyst ... implemented strategies aimed at reducing the volume of ... recycled and recovered.” Still, a large proportion of ...
(Date:9/20/2014)... Linda, CA (PRWEB) September 20, 2014 ... will receive a $250,000 pediatric cancer research grant from ... at Loma Linda University Children’s Hospital located on 11234 ... the work of Dr. Kimberley Payne, Associate Professor at ... Payne’s work focuses on leukemia in children. ...
(Date:9/20/2014)... Lifeinsurancequoteterm.net has released a new blog ... life insurance plan provides for vulnerable family members. ... be a top priority for every provider. It is ... medical examinations and visiting a doctor. , Life ... provide coverage up to $300,000, but only to healthy ...
(Date:9/20/2014)... 2014 The festival season is coming soon. ... newly released luxurious cocktail dresses . A lot of ... decided to launch a new promotion for its high quality ... a discounted price, from 20 to 71 percent off. ... of choices. They are provided in many fashionable colors. Mary, ...
Breaking Medicine News(10 mins):Health News:Versatility of Emory Toolbox 4.0 Shown at ASNC in Scientific Posters 2Health News:Versatility of Emory Toolbox 4.0 Shown at ASNC in Scientific Posters 3Health News:Waste Treatment and Disposal Services in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Waste Treatment and Disposal Services in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Loma Linda University Medical Center Receives $250,000 Research Grant From Hyundai Hope On Wheels In Honor Of National Childhood Cancer Awareness Month 2Health News:Loma Linda University Medical Center Receives $250,000 Research Grant From Hyundai Hope On Wheels In Honor Of National Childhood Cancer Awareness Month 3Health News:No Medical Exam Life Insurance Provides Financial Protection for Families 2Health News:High-end Fashion Designer BellasDress Offers Luxurious Cocktail Dresses For Sophisticated Women 2
... body fat for those at risk of insulin resistance , , ... slows the onset of early puberty and reduces the risk ... a Spanish study concludes. , "The findings indicate that ... puberty is faster in girls, the appearance of menses occurs ...
... Company reported in its,PULSE research publication that Blue Cross ... as revenues increased by 7.4% in 2007.,Insured membership decreased ... mean increase of 6.0%., Operating margins declined by ... 39 plans varied; 6 had improvements in operating margins ...
... escalates as state continues to reject appeal for,health insurance ... "The change we need recognizes health as a public ... count on and afford.", - Deval Patrick, 2008 ... ), BOSTON, June 17 The following was ...
... 17 Across industry sectors,sales drive profits. And ... and time management practices,according to benchmarking research from ... study shows the client still remains king for ... of their time,building solutions for clients and 25 ...
... bones don,t heal as they should, experts note , , TUESDAY, ... help improve healing of fractures, a finding that may lead ... of people whose broken bones fail to mend, say researchers ... Adult stems cells are specialized cells that can regenerate damaged ...
... of the connection, study says , , TUESDAY, June 17 ... apparently cuts both ways: Not only are people with ... developing depression, individuals with depression are also at risk ... both doctors and patients need to be more aware ...
Cached Medicine News:Health News:Diabetes Drug May Prevent Early Puberty in Young Girls 2Health News:Home Care Workers, Seniors, Disabled From Across Massachusetts to Protest Poverty Wages, Lack of Health Insurance, Wednesday, June 18 at Office of Governor Deval Patrick 2Health News:Home Care Workers, Seniors, Disabled From Across Massachusetts to Protest Poverty Wages, Lack of Health Insurance, Wednesday, June 18 at Office of Governor Deval Patrick 3Health News:High-Performing Sales Forces Share Key Practices to Achieve Optimal Performance 2Health News:Stem Cells Might Treat Tough Fractures 2Health News:Diabetes and Depression Go Hand-in-Hand 2Health News:Diabetes and Depression Go Hand-in-Hand 3
... The advanced performance benefits of TiMAX™ ... generation of implants. DePuy ACEs Large Fragment ... biocompatibility and enhanced imaging compatibility over traditional ... unique thread design in the TiMAX bone ...
Comprehensive range of integrated implants and instruments including - Basic, Small, Mini, Pelvic and Foot Sets....
Comprehensive range of integrated implants and instruments including - Basic, Small, Mini, Pelvic and Foot Sets....
... Fragment System has been conceived and engineered ... and user-friendly instrumentation. The modular system of ... instrumentation is designed to provide the surgeon ... and classic techniques of open reduction and ...
Medicine Products: